Artia Global Partners LP

Registered adviser

CIK

1937964

Location

MIAMI, FL

Portfolio Value

Small $541,857,811

Diversification

Diversified

Filing Date

Global Rank

#3,645 / 8,819 ▼ 101

Top Industry

Biotechnology 77.6%

3Y Alpha vs SPY

-17.5%

Period ended 4 months ago

Filed Aug 14, 2026 · 3mo

15 quarters · since Dec 2022

Regulatory profile

From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.

Holder type

Registered adviser

Form ADV roster, Oct 1, 2026

Form ADV adviser

CRD 322091

Roster of Oct 1, 2026

Regulatory AUM

$778,890,878

Main clients

Pooled investment vehicles (100% of AUM)

Private funds

1 fund · Hedge funds

Focus by fund count, roster of Oct 1, 2026

$778,890,878 gross assets

LEI

529900VJNLZI3RT4PP73

Private funds on Schedule D 7.B.(1)

As filed Mar 26, 2024; SEC's bulk Form ADV archive ends with 2024 filings.

$428,191,035 gross assets in 1 fund Hedge funds $428,191,035 (1)

Form ADV history

Monthly rosters from Dec 2019; each row is a run with the same figures, newest first.

Rosters	Regulatory AUM	Main clients
Apr 2026 to Oct 2026	$778,890,878	Pooled investment vehicles (100%)
Apr 2025 to Mar 2026	$628,254,289	Pooled investment vehicles (100%)
Apr 2024 to Mar 2025	$428,191,035	Pooled investment vehicles (100%)
May 2023 to Mar 2024	$465,377,123	Pooled investment vehicles (100%)
Apr 2023	$465,377,123	Pooled investment vehicles (100%)
Nov 2022 to Mar 2023	$400,445,466	Pooled investment vehicles (100%)

1 earlier changes not shown.

Portfolio style

Measured from the filed 13F common-share book for Jun 30, 2026, never from the firm's own description.

Style

Concentrated

The top 10 positions are 66.5% of the book (60%+)

Turnover

Medium turnover

48.1% over the last four quarters (30% to under 100%)

Horizon

Medium horizon

Value-weighted holding period 5.9 quarters (4 to under 12)

Closest benchmark: the Russell 2000 as of 2026-06-30, active share 96.8%; sector active share 90.9% against the combined 13F book's sector weights.

Over time 15 measured quarters

How the bands are measured

Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.

Clone Performance

Build a hypothetical price-return history from this filer's public 13F holdings.

View clone backtest

Portfolio Concentration

48 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026

Top Position

12.7%

−17.0 pts

Top 5

45.0%

−14.4 pts

Top 10

64.5%

−9.1 pts

HHI

571

Diversified−655

Portfolio Trend

15 quarters · across all stocks

Sector Breakdown

As of Jun 30, 2026

Sector	% Portfolio	Value	Positions
Healthcare	97.1%	$526,032,811	47
Unclassified	2.9%	$15,825,000	1

Last Quarter's Activity

Export CSV

Jun 30, 2026 vs Mar 31, 2026

Added To

Positions the filer increased

11 positions

Ticker	Company	Δ Shares	Shares	Value
BTSG	BrightSpring Health Services, Inc.	+463,515	517,315	$36,077,548
TVTX	Travere Therapeutics, Inc.	+268,333	339,033	$19,260,464
TRVI	Trevi Therapeutics, Inc.	+197,250	2,210,852	$41,232,389
RVMD	Revolution Medicines, Inc.	+60,400	185,390	$34,719,839
CYTK	Cytokinetics Inc	+54,400	70,700	$6,022,933
ELVN	Enliven Therapeutics, Inc.	+51,200	72,100	$3,659,075
CELC	Celcuity Inc.	+43,740	59,316	$6,205,639
EWTX	Edgewise Therapeutics, Inc.	+33,300	98,800	$4,014,244
DGX	Quest Diagnostics Inc	+24,305	65,122	$13,802,607
AZN	Astrazeneca PLC	+3,000	98,376	$18,654,057
PTGX	Protagonist Therapeutics, Inc	+20	22,951	$2,813,333
No positions match the current search.

Trimmed

Positions the filer reduced

3 positions

Ticker	Company	Δ Shares	Shares	Value
ABVX	Abivax S.A.	−84,300	516,447	$68,821,727
ALMS	Alumis Inc.	−46,500	278,546	$7,838,284
INSM	INSMED Inc	−39,660	589,052	$62,804,724
No positions match the current search.

New Positions

Positions the filer opened this quarter

6 positions

Ticker	Company	Shares	Value
ALKS	Alkermes plc.	448,964	$23,525,713
GH	Guardant Health, Inc.	38,100	$5,716,143
ABSI	Absci Corp	464,444	$5,382,905
ORKA	Oruka Therapeutics, Inc.	33,400	$3,178,678
CMPX	Compass Therapeutics, Inc.	383,200	$839,208
SYRE	Spyre Therapeutics, Inc.	4,000	$355,120
No positions match the current search.

Sold Out

Positions the filer fully exited

7 positions

Ticker	Company	Shares	Value
LLY	ELI LILLY & Co	38,220	$35,153,609
—		104,800	$5,525,056
ABBV	AbbVie Inc.	14,500	$3,153,605
—		68,490	$2,293,045
BBIO	BridgeBio Pharma, Inc.	20,400	$1,514,904
—		5,886	$495,424
AVTX	Avalo Therapeutics, Inc.	28,970	$432,522
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

48 tracked positions · $541,857,811 total · filing declares 48 positions · $541,855,576 · as of Jun 30, 2026

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	Held (qtrs)	Est. cost/share	% of Portfolio
ABVX	Abivax S.A. Healthcare	Reduced	516,447	-84,300	$68,821,727	+2.9%	4	$91.17	12.70%
INSM	INSMED Inc Healthcare	Reduced	589,052	-319,360	$62,804,724	−57.7%	11	$72.29	11.59%
TRVI	Trevi Therapeutics, Inc. Healthcare	Added	2,210,852	+197,250	$41,232,389	+71.6%	5	$7.39	7.61%
BTSG	BrightSpring Health Services, Inc. Healthcare	Added	517,315	+463,515	$36,077,548	+1473.8%	4	$52.57	6.66%
RVMD	Revolution Medicines, Inc. Healthcare	Added	185,390	+60,400	$34,719,839	+185.6%	8	$85.97	6.41%
ARGX	Argenx SE Healthcare	Held	29,739	0	$27,590,952	+27.0%	15	before history	5.09%
ALKS	Alkermes plc. Healthcare	NEW	448,964	NEW	$23,525,713	NEW	1	$39.05	4.34%
TVTX	Travere Therapeutics, Inc. Healthcare	Added	339,033	+268,333	$19,260,464	+816.9%	6	$40.76	3.55%
AZN	Astrazeneca PLC Healthcare	Added	98,376	+3,000	$18,654,057	−0.8%	2	unpriced	3.44%
NAMS	NewAmsterdam Pharma Co N.V. Healthcare	Held	503,936	0	$17,078,391	+5.9%	5	$31.28	3.15%
DNTH	Dianthus Therapeutics, Inc. Healthcare	Held	162,990	0	$15,888,265	+16.2%	4	$31.76	2.93%
XBI	State Street(R) SPDR(R) S&P(R) Biotech ETF PUT	NEW	100,000	NEW	$15,825,000	NEW	—	—	2.92%
DGX	Quest Diagnostics Inc Healthcare	Added	65,122	+24,305	$13,802,607	+72.5%	6	$178.02	2.55%
IONS	Ionis Pharmaceuticals Inc Healthcare	Held	144,376	0	$11,447,573	+5.6%	4	$64.26	2.11%
EYPT	EyePoint, Inc. Healthcare	Held	767,098	0	$10,969,501	+10.9%	11	$11.20	2.02%
ALMS	Alumis Inc. Healthcare	Reduced	278,546	-46,500	$7,838,284	+9.5%	2	$25.00	1.45%
VKTX	Viking Therapeutics, Inc. Healthcare	Held	180,731	0	$7,050,316	+19.9%	15	before history	1.30%
CELC	Celcuity Inc. Healthcare	Added	59,316	+43,740	$6,205,639	+249.1%	3	$107.88	1.15%
CYTK	Cytokinetics Inc Healthcare	Added	70,700	+54,400	$6,022,933	+460.6%	2	$69.90	1.11%
MRK	Merck & Co., Inc. Healthcare	Held	46,700	0	$6,000,950	+6.8%	2	$115.45	1.11%
RAPP	Rapport Therapeutics, Inc. Healthcare	Held	138,508	0	$5,771,628	+33.2%	4	$23.09	1.07%
JNJ	Johnson & Johnson Healthcare	Held	22,600	0	$5,739,722	+3.9%	2	$232.92	1.06%
GH	Guardant Health, Inc. Healthcare	NEW	38,100	NEW	$5,716,143	NEW	1	$108.76	1.05%
ABSI	Absci Corp Healthcare	NEW	464,444	NEW	$5,382,905	NEW	1	$5.63	0.99%
SRRK	Scholar Rock Holding Corp Healthcare	Held	96,285	0	$5,295,675	+11.9%	6	$38.47	0.98%
SION	Sionna Therapeutics, Inc. Healthcare	Held	119,741	0	$5,267,406	+9.7%	3	$37.92	0.97%
ASND	Ascendis Pharma A/S Healthcare	Held	17,740	0	$4,731,612	+16.6%	10	$167.96	0.87%
ROIV	Roivant Sciences Ltd. Healthcare	Held	129,800	0	$4,593,622	+27.8%	3	$19.73	0.85%
PALI	Palisade Bio, Inc. Healthcare	Held	1,992,367	0	$4,164,047	+19.4%	3	$1.92	0.77%
EWTX	Edgewise Therapeutics, Inc. Healthcare	Added	98,800	+33,300	$4,014,244	+94.6%	2	$30.74	0.74%
BIIB	Biogen Inc. Healthcare	Held	18,437	0	$3,983,498	+17.9%	2	$184.26	0.74%
XENE	Xenon Pharmaceuticals Inc. Healthcare	Held	65,000	0	$3,923,400	+3.8%	10	$46.03	0.72%
BLTE	Belite Bio, Inc Healthcare	Held	24,989	0	$3,847,931	−3.4%	3	$132.37	0.71%
MLYS	Mineralys Therapeutics, Inc. Healthcare	Held	137,800	0	$3,717,844	−0.4%	5	$30.39	0.69%
PROK	Prokidney Corp. Healthcare	Held	1,806,939	0	$3,686,155	+14.0%	3	$2.63	0.68%
ELVN	Enliven Therapeutics, Inc. Healthcare	Added	72,100	+51,200	$3,659,075	+346.6%	2	$38.18	0.68%
ORKA	Oruka Therapeutics, Inc. Healthcare	NEW	33,400	NEW	$3,178,678	NEW	1	$66.63	0.59%
PTGX	Protagonist Therapeutics, Inc Healthcare	Added	22,951	+20	$2,813,333	+16.4%	13	$36.61	0.52%
UTHR	UNITED THERAPEUTICS Corp Healthcare	Held	5,000	0	$2,709,150	−8.6%	6	$342.70	0.50%
DRUG	Bright Minds Biosciences Inc. Healthcare	Held	38,407	0	$2,696,171	−3.8%	3	$68.61	0.50%
KNSA	Kiniksa Pharmaceuticals International, plc Healthcare	Held	29,200	0	$1,867,340	+32.8%	5	$25.46	0.34%
CMPX	Compass Therapeutics, Inc. Healthcare	NEW	383,200	NEW	$839,208	NEW	1	$2.95	0.15%
PRAX	Praxis Precision Medicines, Inc. Healthcare	Held	2,500	0	$836,975	+3.9%	3	$186.22	0.15%
KOD	Kodiak Sciences Inc. Healthcare	Held	17,019	0	$663,060	+2.2%	3	$20.48	0.12%
TENX	Tenax Therapeutics, Inc. Healthcare	Held	42,080	0	$612,264	−9.0%	3	$8.70	0.11%
		Held	4,900	0	$605,150	+20.5%	3	unpriced	0.11%
PEPG	PepGen Inc. Healthcare	Held	205,324	0	$369,583	+1.7%	3	$5.19	0.07%
SYRE	Spyre Therapeutics, Inc. Healthcare	NEW	4,000	NEW	$355,120	NEW	1	$72.97	0.07%

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.